{"id":"nasal-beclomethasone-dipropionate","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nasal irritation"},{"rate":null,"effect":"Epistaxis"},{"rate":null,"effect":"Pharyngitis"},{"rate":null,"effect":"Dysgeusia"}]},"_chembl":{"chemblId":"CHEMBL321416","moleculeType":"Small molecule","molecularWeight":"521.05"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a topical intranasal corticosteroid, beclomethasone dipropionate binds to glucocorticoid receptors in nasal mucosa, inhibiting the production of pro-inflammatory cytokines and reducing recruitment of inflammatory cells. This decreases nasal inflammation, congestion, and associated symptoms of allergic and non-allergic rhinitis.","oneSentence":"Beclomethasone dipropionate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:39.806Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis"},{"name":"Non-allergic rhinitis"},{"name":"Nasal polyps (adjunctive therapy)"}]},"trialDetails":[{"nctId":"NCT05970731","phase":"PHASE2","title":"Directed Topical Drug Delivery for Treatment for PASC Hyposmia","status":"COMPLETED","sponsor":"Duke University","startDate":"2023-09-05","conditions":"Post Acute Sequelae Covid-19 Hyposmia","enrollment":16},{"nctId":"NCT04817800","phase":"PHASE1, PHASE2","title":"To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal Spray","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2021-03-25","conditions":"Seasonal Allergic Rhinitis","enrollment":48},{"nctId":"NCT03855189","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1993-08-23","conditions":"Seasonal Allergic Rhinitis","enrollment":345},{"nctId":"NCT03879772","phase":"PHASE3","title":"Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-03-12","conditions":"Rhinitis, Allergic, Seasonal","enrollment":679},{"nctId":"NCT01024608","phase":"PHASE3","title":"Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-12-31","conditions":"Seasonal Allergic Rhinitis, Hay Fever","enrollment":340},{"nctId":"NCT00988247","phase":"PHASE3","title":"Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic Rhinitis","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-10-31","conditions":"Rhinitis, Allergic, Perennial","enrollment":529},{"nctId":"NCT04179461","phase":"PHASE2","title":"Personalized Treatment Algorithms for Difficult-to-treat Asthma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-03-16","conditions":"Asthma in Children","enrollment":21},{"nctId":"NCT01550471","phase":"PHASE4","title":"Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis","status":"COMPLETED","sponsor":"West Penn Allegheny Health System","startDate":"2012-03","conditions":"Asthma, Allergic Rhinitis","enrollment":22},{"nctId":"NCT00346775","phase":"PHASE3","title":"Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":97},{"nctId":"NCT02646904","phase":"PHASE4","title":"Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis","status":"COMPLETED","sponsor":"Stefania La Grutta, MD","startDate":"2016-05","conditions":"Allergic Rhinitis","enrollment":68},{"nctId":"NCT00788463","phase":"PHASE2","title":"A Comparison of Beclomethasone Aqueous Spray and Aerosol Delivery Systems in Nasal Polyps","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2006-11-23","conditions":"Nasal Polyps","enrollment":30},{"nctId":"NCT00659048","phase":"PHASE3","title":"Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-12","conditions":"Rhinitis, Allergic, Perennial","enrollment":106},{"nctId":"NCT01783548","phase":"PHASE3","title":"Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2013-01","conditions":"Allergic Rhinitis","enrollment":547},{"nctId":"NCT01697956","phase":"PHASE3","title":"Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2012-10","conditions":"Allergic Rhinitis","enrollment":99},{"nctId":"NCT01307319","phase":"PHASE3","title":"Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2011-03","conditions":"Seasonal Allergic Rhinitis, SAR","enrollment":715},{"nctId":"NCT02133053","phase":"","title":"Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2011-05","conditions":"Allergic Rhinitis","enrollment":50},{"nctId":"NCT01632540","phase":"","title":"Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2012-07","conditions":"Perennial Allergic Rhinitis (PAR)","enrollment":824},{"nctId":"NCT01133626","phase":"PHASE3","title":"Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-06","conditions":"Perennial Allergic Rhinitis","enrollment":107},{"nctId":"NCT01134705","phase":"PHASE3","title":"Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-05","conditions":"Rhinitis, Allergic, Perennial","enrollment":474},{"nctId":"NCT00854360","phase":"PHASE2","title":"Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-03","conditions":"Seasonal Allergic Rhinitis, Hayfever","enrollment":487},{"nctId":"NCT01537692","phase":"PHASE1","title":"Clinical Study to Evaluate the Pharmacokinetics and Safety of BDP HFA Nasal Aerosol","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2009-03","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT00775489","phase":"NA","title":"Nasal Steroids in Controlled Glaucoma","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2010-01","conditions":"Intraocular Pressure","enrollment":19},{"nctId":"NCT00115089","phase":"PHASE2","title":"7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Rigel Pharmaceuticals","startDate":"2005-07","conditions":"Rhinitis, Allergic, Seasonal","enrollment":375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NBDP"],"phase":"marketed","status":"active","brandName":"Nasal Beclomethasone Dipropionate","genericName":"Nasal Beclomethasone Dipropionate","companyName":"Stefania La Grutta, MD","companyId":"stefania-la-grutta-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Beclomethasone dipropionate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune cell activity and inflammatory mediator release. Used for Allergic rhinitis, Non-allergic rhinitis, Nasal polyps (adjunctive therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}